New method for the detection of reactive oxygen... (2008 study) Skip to main content
Study Free Radic Res 2008

New method for the detection of reactive oxygen species in anti-tumoural activity of adriamycin: a comparison between hypoxic and normoxic cells

Rharass T, Vigo J, Salmon J, Ribou A, Free Radic Res, 2008

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers measured reactive oxygen species (ROS) in human leukemia cells treated with the cancer drug adriamycin, comparing cells grown in low oxygen (2% O2) with cells grown in normal oxygen (21% O2).

What They Found

This laboratory cell study found that adriamycin raised ROS levels more in normal-oxygen cells than in low-oxygen cells at 24 hours, and the authors link this to a moderate improvement in the drug's cell-killing effect. The work used CCRF-CEM cells and a new method that measures ROS through the fluorescence lifetime of 1-pyrenebutyric acid. The authors report that ROS were also generated by a second mechanism tied to disturbed cell function in longer-term studies. Adriamycin stopped the cell cycle from progressing in both low and normal oxygen, which the authors take to mean that oxygen and ROS do not change the drug's DNA-damaging activity.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study used a single cultured human cell line in a laboratory, did not test hyperbaric oxygen or any patients, and the abstract describes the improvement in the drug's cytotoxicity as only moderate.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 18297605
Year Published 2008
Journal Free Radic Res
MeSH Terms Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytological Techniques; DNA Damage; Doxorubicin; Fluorescence; Humans; Oxygen; Pyrenes; Reactive Oxygen Species

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology